StemCells21: Practical, Effective, Science-Driven Treatments Address your underlying condition. Enhance your body’s natural healing methods. Regain a vibrant quality of life. See Conditions Treated > A Next-Generation Approach StemCells21 delivers meaningful health outcomes for the challenging conditions that conventional therapies often fail to address. To do so, we follow a next-generation approach to stem cell treatment. Our approach corrects the issues found in both conventional therapies and mass-market stem cell providers that lead to suboptimal outcomes. We developed our unique approach to stem cell treatment through 12+ years of successful real-world clinical experience and leading-edge scientific experimentation. Along the way, we have cut through the misinformation and over-promising that has weighed down stem cell treatments, and learned how to deliver on their fundamental promise.
Looking for a particular StemCells21 employee's phone or email?
The StemCells21 annual revenue was $5 million in 2026.
Paul Collier is the Managing Director of StemCells21.
10 people are employed at StemCells21.
The NAICS codes for StemCells21 are [6211, 621, 62, 62111, 621111].
The SIC codes for StemCells21 are [80, 801].